Technology News and Research

RSS

OptiMedica to feature Catalys Precision Laser System at Ophthalmology annual meeting

Global ophthalmic device company OptiMedica Corp. has announced that its Catalys Precision Laser System will be featured as part of four clinical presentations at the American Academy of Ophthalmology annual meeting in Chicago on October 16, 17 and 18.

13 Oct 2010

Beryl technology improves relationship between health care providers and consumers

Amongst the many priorities spelled out in the healthcare reform law, one is that hospitals will need to find ways to forge closer relationships with patients. One way to accomplish this is by proactively managing care outside of the hospital setting. Hundreds of hospitals nationwide are using Beryl, a technology-focused patient experience services company dedicated to improving relationships between health care providers and consumers, to proactively contact former and potential patients to encourage them to access free screenings, new service offerings and to schedule annual exams.

13 Oct 2010

Intelerad to feature new technology at RANZCR Annual Meeting

Intelerad Medical Systems, a recognised leader in medical imaging PACS and workflow solutions, will be featuring new technology and solutions at the RANZCR 2010 Annual Scientific Meeting from October 14 to 17, 2010 in Perth, Australia.

13 Oct 2010

Quality Systems wins TechAmerica's 52nd annual Innovator Awards

Quality Systems, Inc. announced today that its chairman of the board and founder, Sheldon Razin, was named the winner in the software category of TechAmerica's 52nd annual Innovator Awards, which honors eight innovators representing different industry segments for their contributions to the technology industry.

13 Oct 2010

SOKO Fitness & Spa Group first quarter revenue increases 42% to $9.1 million

SOKO Fitness & Spa Group, Inc., an operator of fitness centers and beauty salons and spas in Northeast China as well as suburban Beijing, today announced its financial results for the first quarter of fiscal 2011, ended August 31, 2010.

13 Oct 2010

Detect-Ready MRSA assay receives first independent validation

Molecular Detection Inc. a company developing Detect-Ready assays designed to increase the speed and accuracy of infectious disease diagnosis, today announced that its Detect-Ready MRSA assay has received its first independent validation in a study conducted at St. George's Healthcare NHS Trust, a leading teaching hospital in the UK.

13 Oct 2010

Biomerix receives USPTO patent for Biomaterial tissue scaffold

Biomerix Corporation today announced that the United States Patent and Trademark Office (USPTO) has granted a patent for its proprietary biomaterial platform technology titled Reticulated elastomeric matrices, their manufacture and use in implantable devices.

13 Oct 2010

New York Stem Cell Foundation names first six NYSCF Investigators

In an expansion of its ongoing effort to promote the next generation of stem cell scientists, The New York Stem Cell Foundation (NYSCF) today named the first six NYSCF Investigators. Each of the NYSCF-Robertson and NYSCF-Helmsley Investigators will receive up to $1.5 million over the next five years to expand their own laboratories, train other scientists and foster innovative high-risk/high reward research to explore the therapeutic potential of stem cells derived from humans and model organisms.

13 Oct 2010

Medical Exchange announces next generation of continuing medical education events

Medical Exchange, an innovative provider of medical education solutions for the health care industry, today announced the next generation of continuing medical education events with the launch of collaborativeCARE Conference (C3).

13 Oct 2010

Cancer Research UK launches programme to turn genetic revolution into better treatment for cancer patients

Cancer Research UK has launched a multimillion pound programme, alongside the Technology Strategy Board's Innovation Platform, to help turn the genetic revolution into better treatment for cancer patients.

13 Oct 2010

Hospitalizations and associated costs with peripheral artery disease increase as condition progresses

Peripheral artery disease (PAD) is a progressive and costly disease, but remains under-diagnosed and under treated. While current PAD treatments are effective at clearing artery blockages in the lower leg, high recurrence rates and the subsequent need for repeat procedures are costly. Even after initial procedures to clear blockages in leg arteries, hospitalizations and associated costs in patients with peripheral artery disease increase as the condition progresses, according to research reported in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

13 Oct 2010

$1.5 million DOD award allows U-M scientists to pursue new application for nanoemulsion technology

The U.S. Department of Defense has awarded $1.5 million over three years to the Michigan Nanotechnology Institute for Medicine and Biological Sciences and to Ann Arbor-based NanoBio Corporation to develop and test nanoemulsions with potential to fight a wide range of wound infections, including drug-resistant forms.

13 Oct 2010

Pharmalink's Nefecon for IgA nephropathy receives FDA orphan drug designation

Pharmalink AB, a privately held Swedish pharmaceutical company, has received orphan drug designation by the US Food and Drug Administration (FDA) for its product candidate Nefecon (PL-56) for patients with IgA nephropathy, also referred to as Berger's Disease. This program is presently in clinical development phase II.

13 Oct 2010

USPTO grants HemoShear patent for human cell-based surrogate systems

HemoShear LLC, a biotechnology research company and leading developer of human cell-based surrogate systems for discovery and assessment of new drug compounds, today announced that the U.S. Patent and Trademark Office (USPTO) has granted it patent no. 7,811,782 entitled "Use of An In Vitro Hemodynamic Endothelial/Smooth Muscle Cell Co-Culture Model to Identify New Therapeutic Targets for Vascular Disease."

13 Oct 2010

New, longer lasting LVAD implanted in Canadian heart-failure patient

In a Canadian first, the Peter Munk Cardiac Centre used a new kind of left ventricular assist device (LVAD) to treat a patient with advanced heart failure. The new device is longer lasting than older generation LVADs and may eliminate the need for a second LVAD - a major drawback with the old technology.

13 Oct 2010

Prosensa receives £7.5M milestone payment in GSK2402968 Phase IIa trial for DMD

Prosensa, the Dutch biopharmaceutical company focusing on RNA modulating therapeutics, has announced that it received a £7.5m milestone payment from GlaxoSmithKline (GSK) as a result of achieving a data milestone in its Phase IIa open label extension trial of GSK2402968 (PRO051), being developed to treat Duchenne Muscular Dystrophy (DMD) under its agreement with GSK. The milestone payment was based upon achievement of a successful safety review, with no serious safety signals observed.

13 Oct 2010

Genmab and Lundbeck enter agreement to develop antibody therapeutics

Genmab A/S announced today an agreement to create and develop human antibody therapeutics for disorders of the central nervous system (CNS) with H. Lundbeck A/S. Genmab will create novel human antibodies to three targets identified by Lundbeck. Lundbeck will have access to Genmab's antibody creation and development capabilities, including its state of the art, fully automated pre-clinical antibody screening and characterization capabilities and its proprietary stabilized IgG4 and UniBody therapeutic antibody platforms.

13 Oct 2010

Technology News and Research

OptiMedica to feature Catalys Precision Laser System at Ophthalmology annual meeting

Beryl technology improves relationship between health care providers and consumers

Intelerad to feature new technology at RANZCR Annual Meeting

Quality Systems wins TechAmerica's 52nd annual Innovator Awards

SOKO Fitness & Spa Group first quarter revenue increases 42% to $9.1 million

Detect-Ready MRSA assay receives first independent validation

Biomerix receives USPTO patent for Biomaterial tissue scaffold

New York Stem Cell Foundation names first six NYSCF Investigators

Medical Exchange announces next generation of continuing medical education events

Cancer Research UK launches programme to turn genetic revolution into better treatment for cancer patients

Hospitalizations and associated costs with peripheral artery disease increase as condition progresses

$1.5 million DOD award allows U-M scientists to pursue new application for nanoemulsion technology

Pharmalink's Nefecon for IgA nephropathy receives FDA orphan drug designation

USPTO grants HemoShear patent for human cell-based surrogate systems

New, longer lasting LVAD implanted in Canadian heart-failure patient

Prosensa receives £7.5M milestone payment in GSK2402968 Phase IIa trial for DMD

Genmab and Lundbeck enter agreement to develop antibody therapeutics

JAMA publishes Probuphine Phase 3 clinical trial data

Ocular Therapeutix completes Proof of Principle clinical study with moxifloxacin punctum plug

ERYtech Pharma, Genzyme enter collaboration to develop novel therapeutic enzyme formulation

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News